InvestorsHub Logo
icon url

morley480

05/02/10 12:47 AM

#30663 RE: dianebRN #30660

No, BC/BS is not in the high road business but it will be cheaper for them to fund the transplant of stem cells than to transplant an entire heart, or treat long-term leukemia, Parkinson's, ALS, and a hundred other acute and chronic diseases.

Then, if the government (federal or state) gives them a few incentives........

Public/private partnerships, Red Cross, CBAI, insurance companies, teaching/research university hospitals with a leading-edge reputation to promote, countries like China wanting to steal the lead.........

After the damage to the reputation of the financial/banking system and the oil industry reputation currently up in flames in the Gulf, I would think the health care industry would want to pro-actively dodge that bullet.

Although, speaking of the health care industry, CBAI wants to be the stem cell pharma to the world. Do you know how much money the world-wide pharma industry pulls in every year??

Just re-define pharmaceuticals. Private stem cell storage the brand-names and public the generic. But patents only on the process, at least for now.